Genetic predictors of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization

被引：0

作者：

Anne Delbaere

Guillaume Smits

Gilbert Vassart

Sabine Costagliola

机构：

[1] Fertility Clinic,

[2] Erasme Hospital,undefined

[3] and Assistant Researcher in the Laboratory of Research on Human Reproduction,undefined

[4] Free University Brussels,undefined

[5] Institut de Recherche Interdisciplinaire,undefined

[6] Free University Brussels,undefined

[7] Fonds National de la Recherche Scientifique,undefined

[8] the Institut de Recherche Interdisciplinaire,undefined

[9] a Postdoctoral Fellow at the Babraham Institute,undefined

来源：

Nature Clinical Practice Endocrinology & Metabolism | 2006年 / 2卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Ovarian hyperstimulation syndrome (OHSS) is a complication of pregnancy caused by an excessive response to follicle-stimulating hormone (FSH). OHSS can arise spontaneously or after exogenous FSH administration duringin vitrofertilization procedures. Novel genetic predictors of OHSS, including mutations and polymorphisms of the FSH receptor, are described in this Viewpoint.

引用

页码：590 / 591

页数：1

共 50 条

[1] Genetic predictors of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization
Delbaere, Anne
Smits, Guillaume
Vassart, Gilbert
Costagliola, Sabine
[J]. NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2006, 2 (11): : 590 - 591
[2] Prediction of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization
Kahnberg, Annika
Enskog, Anders
Brannstrom, Mats
Lundin, Kersti
Bergh, Christina
[J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2009, 88 (12) : 1373 - 1381
[3] Perinatal outcome among women undergoing in vitro fertilization procedures complicated by ovarian hyperstimulation syndrome
Serdynska-Szuster, Monika
Jedrzejczak, Piotr
Ozegowska, Katarzyna
Korman, Marcin
Pawelczyk, Leszek
[J]. GINEKOLOGIA POLSKA, 2012, 83 (02) : 104 - 110
[4] Use of medroxyprogesterone acetate in women with ovarian endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization
Guo, Haiyan
Wang, Yun
Chen, Qiuju
Chai, Weiran
Sun, Lihua
Ai, Ai
Fu, Yonglun
Lyu, Qifeng
Kuang, Yanping
[J]. SCIENTIFIC REPORTS, 2017, 7
[5] Use of medroxyprogesterone acetate in women with ovarian endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization
Haiyan Guo
Yun Wang
Qiuju Chen
Weiran Chai
Lihua Sun
Ai Ai
Yonglun Fu
Qifeng Lyu
Yanping Kuang
[J]. Scientific Reports, 7
[6] Administration of methylprednisolone to prevent severe ovarian hyperstimulation syndrome in patients undergoing in vitro fertilization
Lainas, T
Petsas, G
Stavropoulou, G
Alexopoulou, E
Iliadis, G
Minaretzis, D
[J]. FERTILITY AND STERILITY, 2002, 78 (03) : 529 - 533
[7] Useful predictors of ovarian stimulation response in women undergoing in vitro fertilization
van der Stege, JG
van der Linden, PJQ
[J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2001, 52 (01) : 43 - 46
[8] Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles
Papanikolaou, EG
Pozzobon, C
Kolibianakis, EM
Camus, M
Tournaye, H
Fatemi, HM
Van Steirteghem, A
Devroey, P
[J]. FERTILITY AND STERILITY, 2006, 85 (01) : 112 - 120
[9] The efficacy of medroxyprogesterone acetate (MPA) in women with endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization
Guo, H.
[J]. HUMAN REPRODUCTION, 2017, 32 : 251 - 251
[10] Development of ovarian hyperstimulation syndrome: interrogation of key proteins and biological processes in human follicular fluid of women undergoing in vitro fertilization
Jarkovska, Karla
Skalnikova, Helena Kupcova
Halada, Petr
Hrabakova, Rita
Moos, Jiri
Rezabek, Karel
Gadher, Suresh Jivan
Kovarova, Hana
[J]. MOLECULAR HUMAN REPRODUCTION, 2011, 17 (11) : 679 - 692

← 1 2 3 4 5 →